Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens.
Purpose: Considerable evidence exists concerning the risk of febrile neutropenia (FN) associated with well-established, older chemotherapy regimens. Little is known, however, about the risks associated with many regimens that were introduced in the past decade and have become the predominant choice...
| Publicado en: | Supportive Care in Cancer Vol. 22; no. 12; pp. 3275 - 3286 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research Journal Article |
| Publicado: |
Springer Nature
Dec2014
|
| Acceso en línea: | Ver este registro en EBSCOhost |